Beatrix D. Hippe

FDA investigator

Appears on 4 documents from 2024 to 2026, mostly at sites in Minnesota. Most often cites control of microbiological contamination (21 CFR 211.113).

4
Documents on file
2.3
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 9 observations

Activity by year

2024: 1, 2026: 3

Where

Minnesota 3 · Arkansas 1

Is Beatrix D. Hippe coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 OurPharma LLCAug 12, 2026 · Fayetteville, Arkansas
483 Ve t erinary Pharmacy CorporationMar 19, 2026 · Saint Peter, Minnesota
483 Birchwood Laboratories, LLCFeb 13, 2026 · Eden Prairie, Minnesota
483 Padagis US LLCSep 6, 2024 · Minneapolis, Minnesota

About this profile

What does Beatrix D. Hippe inspect?

Beatrix D. Hippe appears on 4 documents on file covering 4 sites, mostly in Minnesota.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.166(a)(3) and 21 CFR 211.180.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Beatrix D. Hippe is dated Aug 12, 2026.